Abstract Cannabinoids are emerging as promising treatments for inflammatory diseases such as ulcerative colitis. Specifically, cannabinoid 2 (CB2) receptors, which…
Abstract Inflammatory bowel disease (IBD) is an inflammation of the gastrointestinal tract mainly categorized as Crohn’s disease and ulcerative colitis.…
Abstract Cannabidiol (CBD) is a major non-psychotropic phytocannabinoid that exists in the Cannabis sativa plant. CBD has been found to…
Abstract The pathogenesis of ulcerative colitis (UC) is closely related to severe inflammation, damaged colonic mucosal barrier, increased oxidative stress…
Abstract Background: Though viewed as a potentially safer palliative alternative to opioids, studies of cannabis use for inflammatory bowel disease…
Abstract BACKGROUND: The prevalence of Crohn’s disease (CD) and ulcerative colitis (UC) is on the rise worldwide. This rising prevalence…
Abstract Ulcerative colitis (UC) is an idiopathic, chronic inflammatory disease with multiple genetic and a variety of environmental risk factors.…
Abstract Inflammatory bowel disease (IBD) is a general term used to describe a group of chronic inflammatory conditions of the…
Abstract Inflammatory bowel diseases (IBD) are characterized by a chronic and recurrent gastrointestinal condition, including mainly ulcerative colitis (UC) and…
Abstract Cannabis is the most widely used recreational drug worldwide and is used by some patients with inflammatory bowel disease…